ProStrakan wins German marketing approval for cancer pain drug - Pharmaceutical Business Review

by Pain management @ Fri, 26 Dec 2008 02:00:02 -0600
ProStrakan now plans to launch Abstral in Germany and the UK in the first few weeks of 2009, with further launches across Europe during the year. Abstral (formerly branded as Rapinyl) is a fast-dissolving tablet for sub-lingual administration of ...
  • Recent posts